Pancreatic enhancement after low-dose infusion of Mn-DPDP.
Where this comes from
- Record sourced from PubMed, PMID 1906189.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Enhancement of the pancreas was demonstrated after low-dose (10 mumol/kg) infusion of a new contrast agent for magnetic resonance (MR) imaging, manganese dipyridoxal-diphosphate (Mn-DPDP). To the authors' knowledge, this has not been described previously. The enhancement reached a maximum of 98% +/- 13% (standard deviation) during a long period (greater than 6 hours). Mn-DPDP seems to have potential as a selective contrast agent in MR imaging of the pancreas.
Medical subject headings
- Contrast Media
- Edetic Acid
- Image Enhancement
- Magnetic Resonance Imaging
- Manganese
- Pancreas
- Pyridoxal Phosphate